| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Commentary: Early allogeneic transplantation for chronic myelogenous leukemia in the imatinib era: A preliminary assessment
|
Radich, Jerald
|
|
2006
|
37 |
2 |
p. 125-127
3 p.
|
artikel
|
| 2 |
Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: A preliminary assessment
|
Simon, William
|
|
2006
|
37 |
2 |
p. 116-124
9 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2006
|
37 |
2 |
p. CO2-
1 p.
|
artikel
|
| 4 |
Enhanced oxidative cross-linking of hemoglobin E with spectrin and loss of erythrocyte membrane asymmetry in hemoglobin Eβ-thalassemia
|
Datta, Poppy
|
|
2006
|
37 |
2 |
p. 77-81
5 p.
|
artikel
|
| 5 |
Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human β-globin gene cluster
|
de Andrade, Tiago Gomes
|
|
2006
|
37 |
2 |
p. 82-90
9 p.
|
artikel
|
| 6 |
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran
|
Rahimi, Zohreh
|
|
2006
|
37 |
2 |
p. 91-94
4 p.
|
artikel
|
| 7 |
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure
|
Savage, Sharon A.
|
|
2006
|
37 |
2 |
p. 134-136
3 p.
|
artikel
|
| 8 |
PKR activation by a non-coding RNA expressed in lymphocytes of mice bearing B16 melanoma
|
Murad, Joana M.
|
|
2006
|
37 |
2 |
p. 128-133
6 p.
|
artikel
|
| 9 |
Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy
|
Limdi, N.A.
|
|
2006
|
37 |
2 |
p. 100-106
7 p.
|
artikel
|
| 10 |
Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population
|
Dalmáz, C.A.
|
|
2006
|
37 |
2 |
p. 107-110
4 p.
|
artikel
|
| 11 |
Stimulation of non-transferrin iron uptake by iron deprivation in K562 cells
|
Kovar, Jan
|
|
2006
|
37 |
2 |
p. 95-99
5 p.
|
artikel
|
| 12 |
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years
|
Piazza, Rocco G.
|
|
2006
|
37 |
2 |
p. 111-115
5 p.
|
artikel
|
Tijdschrift beschrijving